BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2301483)

  • 1. Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies.
    Rubin GL; Peterson HB; Lee NC; Maes EF; Wingo PA; Becker S
    Am J Obstet Gynecol; 1990 Jan; 162(1):148-54. PubMed ID: 2301483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
    McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
    Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estrogen therapy and carcinoma of the endometrium (author's transl)].
    Völker W; Kannengiesser U; Majewski A; Vasterling HW
    Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):735-43. PubMed ID: 210085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of endometrial cancer in young women.
    Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
    Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous estrogens and endometrial cancer.
    Gordan GS; Greenberg BG
    Postgrad Med; 1976 Jun; 59(6):66-77. PubMed ID: 778818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
    Brinton LA; Hoover RN
    Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
    Berger GS; Fowler WC
    J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
    Cramer DW; Knapp RC
    Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens and endometrial carcinoma.
    Gray LA; Christopherson WM; Hoover RN
    Obstet Gynecol; 1977 Apr; 49(4):385-9. PubMed ID: 193072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of exogenous estrogen therapy and endometrial cancer.
    Jelovsek FR; Hammond CB; Woodard BH; Draffin R; Lee KL; Creasman WT; Parker RT
    Am J Obstet Gynecol; 1980 May; 137(1):85-91. PubMed ID: 7369293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term estrogen replacement therapy. II. Neoplasia.
    Hammond CB; Jelovsek FR; Lee KL; Creasman WT; Parker RT
    Am J Obstet Gynecol; 1979 Mar; 133(5):537-47. PubMed ID: 220875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen use and endometrial cancer.
    Greenblatt RB
    N Engl J Med; 1979 Apr; 300(16):921-2. PubMed ID: 423940
    [No Abstract]   [Full Text] [Related]  

  • 14. A case-control study of cancer of the endometrium.
    Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Mostow ED; Schwartz PE; O'Connor T; White C
    Am J Epidemiol; 1982 Aug; 116(2):333-42. PubMed ID: 7114042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen regimen of women with endometrial carcinoma. A retrospective case-control study at Radiumhemmet.
    Obrink A; Bunne G; Collén J; Tjernberg B
    Acta Obstet Gynecol Scand; 1981; 60(2):191-7. PubMed ID: 7246086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS; Sayvetz TA
    N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk.
    Key TJ; Pike MC
    Br J Cancer; 1988 Feb; 57(2):205-12. PubMed ID: 3358913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen replacement therapy and endometrial cancer: the elusive link.
    Maggio M
    J Nurse Midwifery; 1980; 25(2):19-21. PubMed ID: 6898648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer and estrogen use. Report of a large case-control study.
    Antunes CM; Strolley PD; Rosenshein NB; Davies JL; Tonascia JA; Brown C; Burnett L; Rutledge A; Pokempner M; Garcia R
    N Engl J Med; 1979 Jan; 300(1):9-13. PubMed ID: 213722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.